Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Corey C. Foster, Marcus A. Couey, Sara E. Kochanny, Arun Khattri, Rajesh K. Acharya, Yi Hung Carol Tan, Ryan J. Brisson, Rom S. Leidner, Tanguy Y. Seiwert

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences